A review of onabotulinumtoxinA (Botox)

OnabotulinumtoxinA was introduced to the US market in 2002 as the first botulinum toxin type A (BoNTA) approved for facial aesthetics. This article provides an overview of onabotulinumtoxinA's uses and indications as well as safety and efficacy data. As with other BoNTA products, onabotulinumto...

Full description

Saved in:
Bibliographic Details
Published in:Aesthetic surgery journal 2013-03, Vol.33 (1 Suppl), p.9S-12S
Main Authors: Lorenc, Z Paul, Kenkel, Jeffrey M, Fagien, Steven, Hirmand, Haideh, Nestor, Mark S, Sclafani, Anthony P, Sykes, Jonathan M, Waldorf, Heidi A
Format: Article
Language:English
Subjects:
Botulinum Toxins, Type A - therapeutic use
Humans
Rejuvenation
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:OnabotulinumtoxinA was introduced to the US market in 2002 as the first botulinum toxin type A (BoNTA) approved for facial aesthetics. This article provides an overview of onabotulinumtoxinA's uses and indications as well as safety and efficacy data. As with other BoNTA products, onabotulinumtoxinA is generally well tolerated. Consideration is also given to clinical applications of the product. Information on handling, storage, and dosing is provided.
ISSN:1090-820X
1527-330X
DOI:10.1177/1090820X12474629